Known targets — ChEMBL curated mechanism
rplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmHrpmIrpmJrpmJ2rpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsU
The experimentally established mechanism targets of Tobramycin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 6/20 | 0.55 |
| ▸ | AKR1C3 | P42330 | 5/20 | 0.55 |
| ▸ | AKR1C2 | P52895 | 4/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.55 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | PTGES | O14684 | 1/20 | 0.55 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.55 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.55 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.55 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | ALB | P02768 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16009661 | 0.90 | PTGS2 (0.53) | PTGS2AKR1C3PTGS1GLO1HIF1A | |
| SCHEMBL16024207 | 0.90 | PTGS2 (0.53) | PTGS2AKR1C3PTGS1GLO1HIF1A | |
| SCHEMBL16017874 | 0.89 | PTGS2 (0.52) | PTGS2AKR1C3PTGS1GLO1HIF1A | |
| SCHEMBL16010034 | 0.86 | PTGS2 (0.53) | PTGS2AKR1C3PTGS1GLO1HIF1A | |
| Indomethacin SCHEMBL5492772 | 0.81 | PTGS2 (0.64) | PTGS2AKR1C3AKR1C2PTGS1MEN1 | |
| Indomethacin SCHEMBL28124710 | 0.79 | AKR1C3 (0.69) | PTGS2AKR1C3AKR1C2PTGS1MEN1 | |
| Betadex SCHEMBL11491489 | 0.75 | AKR1C3 (0.71) | PTGS2AKR1C3AKR1C2PTGS1MEN1 | |
| Betadex SCHEMBL30950731 | 0.75 | AKR1C3 (0.71) | PTGS2AKR1C3AKR1C2PTGS1MEN1 | |
| Indomethacin SCHEMBL29525957 | 0.74 | PTGS2 (1.00) | PTGS2AKR1C3AKR1C2PTGS1MEN1 | |
| Indomethacin SCHEMBL29353712 | 0.74 | PTGS2 (1.00) | PTGS2AKR1C3AKR1C2PTGS1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2964265-A1 | ANTIBIOTIC CONJUGATES WITH NONSTEROIDAL ANTI-INFLAMMATORY DRUGS | ALLERGAN, INC. (US) | 2016-01-13 | — | — | EP | disclosed |
| WO-2014138343-A1 | ANTIBIOTIC CONJUGATES WITH NONSTEROIDAL ANTI-INFLAMMATORY DRUGS | ALLERGAN, INC. (US) | 2014-09-12 | — | — | WO | disclosed |